Federal contractor · public award history
MAPP BIOPHARMACEUTICAL, INC.
Parent: MAPP BIOPHARMACEUTICAL, INC. M9V9QTHR1H28
- Awards we know about
- 7
- Typical size
- $37.51M
- Middle of their public awards
- Dollars on those awards
- $438.17M
Most of their awards we can see fall roughly between $22.64M and $83.79M.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Public award activity by year
Sum of award values in our USAspending index (not a full financial history).
- 2024$16.41M
- 2025$421.75M
Awarding agencies
- Department of Health and Human Services (7)
Industries & product codes
Award history
- Department of Health and Human Services$28.87M
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP
- Department of Health and Human Services$110.88M
THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR THE TREATMENT OF MARBURG VIRUS INFECTION.
- Department of Health and Human Services$37.51M
MAPP 2019 CONTRACT
- Department of Health and Human Services$184.79M
PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES
- Department of Health and Human Services$3.00M
DEVELOPMENT OF MEDICAL COUNTERMEASURES THROUGH PLANNED CLINICAL TRIALS AND OUTBREAK PREPAREDNESS
- Department of Health and Human Services$56.70M
IGF::OT::IGF
- Department of Health and Human Services$16.41M
DEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASURE
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.